| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.3 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |